【摘要】：軟組織腫瘤在形態(tài)學(xué)上較為特殊,其鑒別診斷常較為困難,需要借助于免疫組織化學(xué)及分子病理檢測(cè)。隨著分子遺傳學(xué)的發(fā)展,診斷用抗體不斷被開發(fā),靶向位點(diǎn)不斷被發(fā)現(xiàn)并應(yīng)用于實(shí)踐,為深入研究軟組織腫瘤的分子機(jī)制,進(jìn)而提高對(duì)軟組織腫瘤的診療水平提供了基礎(chǔ),臨床上個(gè)體化診療及精準(zhǔn)醫(yī)學(xué)治療也得到了廣泛的開展。
[Abstract]:Soft tissue tumors are very special in morphology, and their differential diagnosis is often difficult, which needs to be detected by immunohistochemistry and molecular pathology. With the development of molecular genetics, diagnostic antibodies have been developed and targeted sites have been found and applied in practice, which provides a basis for further study of molecular mechanism of soft tissue tumors and further improvement of diagnosis and treatment of soft tissue tumors. Individualized diagnosis and treatment and accurate medical treatment have also been widely carried out.
【作者單位】： 北京大學(xué)腫瘤醫(yī)院f簾本┦兄琢齜樂窩芯克±砜，

本文編號(hào)：2423001